. Author manuscript; available in PMC: 2020 Mar 28.

Published in final edited form as: J Am Coll Cardiol. 2019 Mar 5;73(8):893–902. doi: 10.1016/j.jacc.2018.11.056

Table 2:

Association between diabetes history and medication use reported at 60-day visit

	Proportion Using Medications(No. Reported/Sample Size)		Unadjusted^*		Adjusted^†
Medication	Diabetes	No Diabetes	Odds Ratio (95% CI)	P-value	Odds Ratio (95% CI)	P-value
Aspirin
Diabetes vs. No Diabetes	1034/1733 (59.7%)	3110/6226 (50.0%)	1.48 (1.33–1.65)	<0.001	1.50 (1.34–1.67)	<0.001
Statin
Diabetes vs. No Diabetes	1175/1733 (67.8%)	3076/6226 (49.4%)	2.16 (1.93–2.41)	<0.001	2.19 (1.95–2.45)	<0.001
Beta-blocker
Diabetes vs. No Diabetes	594/1733 (34.3%)	1744/6226 (28.0%)	1.34 (1.20–1.50)	<0.001	1.34 (1.19–1.50)	<0.001
ACEi/ARB
Diabetes vs. No Diabetes	1207/1733 (69.7%)	2337/6226 (37.5%)	3.82 (3.40–4.28)	<0.001	3.84 (3.42–4.31)	<0.001

Unadjusted model contains diabetes mellitus.

^†

Adjusted model controls for noninvasive test modality, age, and sex.

ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; CI, confidence interval.